Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases

A. D. Petrova; Петрова А. Д.; M. B. Stenina; Стенина М. Б.; L. V. Manzyuk; Манзюк Л. В.; N. V. Lyubimova; Любимова Н. В.; S. A. Tyulyandin; Тюляндин С. А.

doi:10.17650/1994-4098-2013-0-1-2-23-27

Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases

Authors: Petrova A.D.¹, Stenina M.B.¹, Manzyuk L.V.¹, Lyubimova N.V.¹, Tyulyandin S.A.¹
Affiliations:
1. N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Issue: No 1-2 (2013)
Pages: 23-27
Section: MAMMOLOGY. TREATMENT
Published: 21.05.2013
URL: https://ojrs.abvpress.ru/ojrs/article/view/36
DOI: https://doi.org/10.17650/1994-4098-2013-0-1-2-23-27
ID: 36

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The paper gives the results of evaluating the time course of changes in the level of bone resorption markers (S-CTx and dPir) in pami- dronate-treated patients with bone metastases from breast cancer. It shows the relationship of these markers to clinical and X-ray find- ings. The markers were not found to be of high clinical significance as a means for diagnosing bone metastases and estimating treat- ment trends.